13D Filing: Venrock Associates Vi, L.p. and Castlight Health Inc. (NYSE:CSLT)

Page 1 of 18

You can access the original SEC filing by clicking here.

Ownership Summary Table

Name Sole Voting Power Shared Voting Power Sole Dispositive Power Shared Dispositive Power Aggregate Amount Owned Power Percent of Class
VENROCK ASSOCIATES V 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK ENTREPRENEURS FUND V 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK PARTNERS V 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK MANAGEMENT V 0 20,783,255 0 20,349,930 20,783,255 22.2%
VEF MANAGEMENT V 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK PARTNERS MANAGEMENT V 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK ASSOCIATES VI 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK PARTNERS VI 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK MANAGEMENT VI 0 20,783,255 0 20,349,930 20,783,255 22.2%
VENROCK PARTNERS MANAGEMENT VI 0 20,783,255 0 20,349,930 20,783,255 22.2%

Page 1 of 18 – SEC Filing

 

 

UNITED STATES

 

 

SECURITIES AND EXCHANGE COMMISSION

 

 

Washington, D.C. 20549

 

 

 

 


 

 

SCHEDULE 13D/A

 

 

Under the Securities Exchange Act of 1934
(Amendment No. 1)*

 

CASTLIGHT HEALTH, INC.

(Name of Issuer)

 

CLASS B COMMON STOCK

(Title of Class of Securities)

 

14862Q100

(CUSIP Number)

 

Attention: General Counsel

Venrock

3340 Hillview Avenue

Palo Alto, California 94304

Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)

 

April 3, 2017

(Date of Event Which Requires Filing of this Statement)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box. o

Note: Schedules filed in paper format shall include a signed original and five copies of the schedule, including all exhibits. See Rule.13d-7 for other parties to whom copies are to be sent.

* The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

 


Follow Castlight Health Inc. (NYSE:CSLT)

Page 1 of 18